Cumberland Pharmaceuticals   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Nashville TN United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2000
NCT00492037
First Marketed Drug
1999
lactulose (cephulac)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Cumberland Pharmaceuticals | Cumberland Pharmaceuticals Inc | Cumberland Pharmaceuticals Inc. | CUMBERLAND PHARMS | CUMBERLAND SWAN